There are several ways to support the QiC Programme, and partners have the opportunity to help develop the programme alongside NHS and patient group experts.
Sanofi
“As the UK&IE Medical Head (Interim) General Medicines at Sanofi, I’m proud of our support for the 2025 QIC Programme. This initiative exemplifies the NHS’s core value of commitment to quality care. By recognizing and rewarding innovations that benefit people living with diabetes, the QIC Programme is driving meaningful improvements in healthcare. It serves as a platform for sharing best practices and novel solutions to daily challenges faced by both healthcare professionals and individuals impacted by diabetes. The QIC Programme truly embodies the NHS’s dedication to excellence in patient care.“
Karen Palmer, Head of Medical General Medicines UKIE (Interim), Sanofi
Karen Palmer, Sanofi
Khizer Jehangir, Sanofi
These videos has been made possible with sponsorship from Sanofi. Sanofi has had no editorial control over any of its contents.
